RELN and neoplasm: In the current study, we demonstrated that integrin α3β1, a major receptor for laminins in the ECM, represses the expression of the RELN gene in TNBC cells, thereby identifying a novel, integrin-dependent regulation of tumor cell secretome component that modulates invasive potential.